CA2271799A1 - Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodescorrespondantes - Google Patents
Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodescorrespondantes Download PDFInfo
- Publication number
- CA2271799A1 CA2271799A1 CA002271799A CA2271799A CA2271799A1 CA 2271799 A1 CA2271799 A1 CA 2271799A1 CA 002271799 A CA002271799 A CA 002271799A CA 2271799 A CA2271799 A CA 2271799A CA 2271799 A1 CA2271799 A1 CA 2271799A1
- Authority
- CA
- Canada
- Prior art keywords
- bismuth
- days
- milligrams
- composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des méthodes et des compositions pour traiter les troubles gastro-intestinaux provoqués par Helicobacter pylori, contenant du bismuth, une quantité gastropathique d'un médicament anti-inflammatoire non stéroïdien et une quantité suffisante pour avoir un effet thérapeutique d'un ou de plusieurs anti-microbiens. La composition peut également contenir une quantité suffisante pour avoir un effet thérapeutique, d'un ou de plusieurs médicaments anti-sécrétoires.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75551896A | 1996-11-22 | 1996-11-22 | |
US08/755,518 | 1996-11-22 | ||
PCT/US1997/021461 WO1998022117A1 (fr) | 1996-11-22 | 1997-11-21 | Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodes correspondantes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2271799A1 true CA2271799A1 (fr) | 1998-05-28 |
Family
ID=25039486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002271799A Abandoned CA2271799A1 (fr) | 1996-11-22 | 1997-11-21 | Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodescorrespondantes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0941101A1 (fr) |
CA (1) | CA2271799A1 (fr) |
NO (1) | NO992469L (fr) |
WO (1) | WO1998022117A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
WO1999010000A1 (fr) * | 1997-08-25 | 1999-03-04 | The Procter & Gamble Company | Preparations combinees pour le traitement des douleurs du tractus gastro-intestinal superieur |
IL145220A0 (en) * | 1999-05-20 | 2002-06-30 | Par Pharmaceutical Inc | Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process |
TWI243672B (en) * | 1999-06-01 | 2005-11-21 | Astrazeneca Ab | New use of compounds as antibacterial agents |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
IL142037A0 (en) * | 2001-03-15 | 2002-03-10 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US6926907B2 (en) | 2001-06-01 | 2005-08-09 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
JP5035865B2 (ja) * | 2005-09-26 | 2012-09-26 | 国立大学法人高知大学 | Helicobacterpylori菌株の増殖・運動抑制方法 |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
JP2012531409A (ja) | 2009-06-25 | 2012-12-10 | アストラゼネカ・アクチエボラーグ | Nsaid関連潰瘍を発症するリスクがある患者の処置方法 |
BR112014016085A8 (pt) | 2011-12-28 | 2017-07-04 | Pozen Inc | composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico |
CA2900763C (fr) | 2013-02-13 | 2021-04-06 | Reza Fathi | Compositions pharmaceutiques destinees au traitement d'helicobacter pylori |
US11096948B2 (en) * | 2016-01-21 | 2021-08-24 | Dexcel Pharma Technologies Ltd. | Methods for treating helicobacter infection |
US11878011B2 (en) | 2020-05-07 | 2024-01-23 | Redhill Biopharma Ltd. | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI910088A (fi) * | 1990-01-09 | 1991-07-10 | Gist Brocades Nv | Oral farmaceutisk komposition. |
DK0550083T3 (da) * | 1991-12-06 | 1999-10-11 | Glaxo Group Ltd | Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra |
-
1997
- 1997-11-21 CA CA002271799A patent/CA2271799A1/fr not_active Abandoned
- 1997-11-21 WO PCT/US1997/021461 patent/WO1998022117A1/fr not_active Application Discontinuation
- 1997-11-21 EP EP97948489A patent/EP0941101A1/fr not_active Withdrawn
-
1999
- 1999-05-21 NO NO992469A patent/NO992469L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO992469L (no) | 1999-07-22 |
NO992469D0 (no) | 1999-05-21 |
EP0941101A1 (fr) | 1999-09-15 |
WO1998022117A1 (fr) | 1998-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2271799A1 (fr) | Compositions de traitement de troubles gastro-intestinaux contenant du bismuth, des anti-inflammatoires non steroidiens ainsi qu'un ou plusieurs agents anti-microbiens et methodescorrespondantes | |
EP0941102A1 (fr) | Compositions et methodes pour traiter des troubles gastro-intestinaux | |
Malfertheiner et al. | Helicobacter pylori: perspectives and time trends | |
JPH0794390B2 (ja) | 胃腸疾患の治療のための医薬組成物 | |
JP5908569B2 (ja) | 胃腸疾患を治療するための方法 | |
EP0206626B1 (fr) | Utilisation de bismuth pour la fabrication d'un médicament destiné au traitement des désordres gastrointestinaux dûs à Campylobacter polyridis | |
Lane et al. | Recurrence of duodenal ulcer after medical treatment | |
US5407688A (en) | Compositions and methods for treating gastrointestinal disorders | |
US5403830A (en) | Compositions and methods of treating gastrointestinal disorders | |
Graham et al. | Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. | |
Holle | Pathophysiology and modern treatment of ulcer disease | |
EP2705845A1 (fr) | Combinaison de sel de zinc et d'agent anti-h pilori comme inhibiteur à action rapide de la sécrétion d'acide gastrique | |
US5447923A (en) | Methods and compositions of diphenyl ether phosphate esters for the treatment of gastrointestinal disorders | |
US4940695A (en) | Bismuth-containing pharmaceutical compositions | |
Porro et al. | Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. | |
Dooley | Helicobacter pylori: review of research findings | |
JP2669818B2 (ja) | 胃腸障害の治療及び予防のためのニトロフラントインの使用 | |
WO1996024342A1 (fr) | Traitement concomitant a base de composes au bismuth par voie orale | |
Ansorg et al. | Susceptibility of Helicobacter pylori to simethicone and other non-antibiotic drugs | |
JP2006506409A (ja) | 合成ラクトン処方物ならびに方法および使用 | |
CA2239420C (fr) | Compositions destinees a la prevention et au traitement de troubles gastro-intestinaux et comprenant du bismuth ainsi qu'un ou plusieurs agents antimicrobiens | |
Graham et al. | Omeprazole as an adjuvant to antimicrobial therapy for eradication of Helicobacter pylori infection | |
Dahlgren et al. | Organobismuth compounds: activity against Helicobacter pylori | |
Tafaj et al. | Acute Esophageal Necrosis. A Case Report. | |
Furukawa et al. | Low-dose aspirin delays gastric healing after Helicobacter pylori eradication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |